PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ∞ AND METABOLIC DISEASE
Timothy Mark Willson, Millard H. Lambert, Steven A. Kliewer · 2001
■ Abstract The nuclear peroxisome proliferator‐activated receptor∞ (PPAR∞ )i s a transcription factor that is activated by polyunsaturated fatty acids and their metabolites and is essential for fat cell formation. Although obesity is a strong risk factor for type 2 diabetes mellitus and other metabolic diseases, potent PPAR∞ activators such as the glitazone drugs lower glucose and lipid levels in patients with type 2 diabetes and also have antiatherosclerotic and antihypertensive effects. We review recent studies providing insight into the paradoxical relationship between PPAR∞ and metabolic disease. We also review recent advances in understanding the structural basis for PPAR∞ activation by ligands. The unusual ligand-binding properties of PPAR∞ suggest that it will be possible to discover new chemical classes of receptor “modulators” with distinct pharmacological activities for the treatment of type 2 diabetes and other metabolic diseases.
Cited by 154 works.
Authors
References
- The nuclear receptor superfamily: The second decade
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
- The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors
- A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
- A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
- The RXR heterodimers and orphan receptors